ALMS Stock Analysis: Buy, Sell, or Hold?
ALMS - Alumis Inc. Common Stock
$26.50
-0.14 (-0.53%)
▼
5d:
+5.87%
30d:
+32.24%
90d:
+16.59%
BUY
MODERATE Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 12, 2026
Get Alerted When ALMS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: ALMS shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: ALMS shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: ALMS is currently trading at $26.50, which is considered extended relative to its 30-day fair value range of $20.19 to $25.45.
Technical Outlook: Technically, ALMS is in a downtrend. Immediate support is located at $22.81, while resistance sits at $28.65.
Market Sentiment: ALMS has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $40.10 (+51.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ALMS is in a downtrend. Immediate support is located at $22.81, while resistance sits at $28.65.
Market Sentiment: ALMS has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $40.10 (+51.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$20.19 -
$25.45
Company Quality Score
60/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
63.2%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 51.3% below Wall St target ($40.10)
Trading Range Analysis
30-Day Trading Range
$20.19 -
$25.45
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$22.81
Resistance Level
$28.65
Current Trend
Downtrend
Technical data as of
Jul 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-8.97
Wall Street Target
$40.10
(+51.3%)
Revenue Growth (YoY)
-90.0%
Share & Embed Analysis
Last updated: July 02, 2026 9:38 PM ET
Data refreshes hourly during market hours. Next update: 10:38 PM
Data refreshes hourly during market hours. Next update: 10:38 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ALMS showing a specific setup today?
Insider Activity (6 Months)
4
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Srinivas Akkaraju
BUY
588235 shares
2026-01-09
Foresite Capital Managem…
BUY
411764 shares
2026-01-08
Foresite Labs, Llc
BUY
411764 shares
2026-01-08
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 56 HOLD |
|
ASND
Ascendis Pharma AS |
STRONG BUY
16 analysts |
$291 | 63 BUY |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$110 | 61 BUY |
|
CLDX
Celldex Therapeutics Inc |
STRONG BUY
15 analysts |
$58 | 57 HOLD |
|
RVMD
Revolution Medicines Inc |
STRONG BUY
12 analysts |
$189 | 62 BUY |
Advanced ALMS Option Strategies
Professional options setups generated by AI based on today's ALMS price and gamma walls.
